bibliographic entry 2179150 [be/2179150]
https://w3id.org/oc/corpus/be/2179150

is a
content
  • Papp, K, Reich, K, Leonardi, CL, Kircik, L, Chimenti, S, Langley, RG. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (efficacy and safety trial evaluating the effects of apremilast in psoriasis [ESTEEM] 1), J Am Acad Dermatol, 2015, 73, 1, 37, 49, DOI: 10.1016/j.jaad.2015.03.049, PMID: 26089047
references